These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10701314)
21. Unmet challenges in HIV therapy and potential of stampidine. Uckun FM Arzneimittelforschung; 2006 Feb; 56(2A):117-20. PubMed ID: 16570820 [No Abstract] [Full Text] [Related]
22. Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient. Tachikawa N; Yasuoka A; Oka S Jpn J Infect Dis; 1999 Dec; 52(6):245-6. PubMed ID: 10738363 [No Abstract] [Full Text] [Related]
24. Final analysis of stavudine. AIDS Patient Care; 1995 Oct; 9(5):257. PubMed ID: 11361414 [No Abstract] [Full Text] [Related]
25. WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic. Fleck F Bull World Health Organ; 2004 Jan; 82(1):77-8. PubMed ID: 15106303 [No Abstract] [Full Text] [Related]
26. FDA notifications. Generic stavudine and efavirenz are tentatively approved by FDA. AIDS Alert; 2008 Apr; 23(4):46. PubMed ID: 19253455 [No Abstract] [Full Text] [Related]
27. FDA notifications. Tentative approval granted for lamivudine/stavudine. AIDS Alert; 2008 Aug; 23(8):92-3. PubMed ID: 18727174 [No Abstract] [Full Text] [Related]
29. New developments in antiretroviral treatment. Sadovsky R Am Fam Physician; 1999 Dec; 60(9):2663, 2666. PubMed ID: 10605997 [No Abstract] [Full Text] [Related]
30. Delavirdine dilemma at the FDA. Food and Drug Administration. Smart T GMHC Treat Issues; 1996 Dec; 10(12):4-5. PubMed ID: 11364017 [TBL] [Abstract][Full Text] [Related]
31. FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet. AIDS Alert; 2009 Sep; 24(9):105-6. PubMed ID: 19938312 [No Abstract] [Full Text] [Related]
32. FDA notifications. Lamivudine/zidovudine combination approved for pediatric use. AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19938311 [No Abstract] [Full Text] [Related]
33. dNN study: stavudine, nelfinavir and nevirapine. Preliminary safety, activity and pharmacokinetic interactions. Skowron G Antivir Ther; 1998; 3 Suppl 4():61-2. PubMed ID: 10723513 [TBL] [Abstract][Full Text] [Related]
34. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see. Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699 [TBL] [Abstract][Full Text] [Related]
35. Retrovir efficacy supplement approved. AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043841 [No Abstract] [Full Text] [Related]
36. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1. Krogstad P; Lee S; Johnson G; Stanley K; McNamara J; Moye J; Jackson JB; Aguayo R; Dieudonne A; Khoury M; Mendez H; Nachman S; Wiznia A; Clin Infect Dis; 2002 Apr; 34(7):991-1001. PubMed ID: 11880966 [TBL] [Abstract][Full Text] [Related]
38. [AIDS: the myth of Sisyphus]. Jaubert D Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577 [No Abstract] [Full Text] [Related]
39. Standard treatments for HIV, Spring 1997. Smith D AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255 [TBL] [Abstract][Full Text] [Related]